iotaMotion Achieves Major Milestone with Robotic Cochlear Implant Technology in Switzerland

iotaMotion Expands Robotic Cochlear Implant Technology Internationally

In a groundbreaking move, iotaMotion, Inc. has announced the first deployment of its iotaSOFT® Insertion System outside the United States. The technology is currently undergoing clinical investigation at the University Hospital of Zurich, emerging as a noteworthy step in advancements for cochlear implant surgery.

Professor Alexander Huber, leading the study that examines "electrocochleographic signals during speed-controlled cochlear implant electrode array insertion," emphasizes the importance of this new robotic-assisted technology for enhancing patient care in cochlear implantation. Over 750 cases utilizing the iotaSOFT system have already occurred in the U.S., showcasing its potential for optimizing intracochlear recordings through real-time electrocochleography (ECochG).

The clinical trial marks a pivotal moment for both iotaMotion and the cochlear implant market, utilizing innovative robotic control during electrode insertions. This process will analyze the interaction between these insertions and cochlear function as indicated by ECochG signals, possibly reshaping future strategies for cochlear implant programming and aiding in hearing preservation.

Mike Lobinsky, the CEO of iotaMotion, expresses his enthusiasm, stating, “This represents a major milestone as we expand our technology offerings internationally. Our collaboration with the Zurich team has been exceptional, and we are eager to further our partnership.” The iotaSOFT system is currently under pre-market clinical investigation, with wider availability anticipated for 2026.

The iotaSOFT® Insertion System represents a unique robotic solution designed to facilitate a slow and controlled electrode array insertion, helping to protect the delicate structures within the cochlea. iotaMotion’s commitment is to transcend the limitations of human capability in medical technology and achieve greater surgical precision in cochlear implant procedures.

As iotaMotion expands its influence beyond U.S. borders, it signifies not only progress for the company but also enhanced opportunities for patients to receive advanced treatment options. The future looks bright for cochlear implant technology, with innovative solutions paving the way for improved auditory outcomes.

For more details on iotaMotion and its revolutionary cochlear implant solutions, visit iotaMotion. Those interested can reach out to Wade Colburn, the Vice President of Marketing and Clinical, via email at [email protected].

As we look ahead, iotaMotion's expansion into the Swiss market exemplifies how international collaboration can lead to significant advancements in medical technology, particularly in enhancing the lives of those with hearing impairment.